MGMT and glioblastoma: To evaluate the clinical relevance of our 2-step TL framework, we compared it with the performance using the methylation status and expression of the MGMT gene; the most well-studied predictive marker of TMZ response in patients with GBM.18 The MGMT promoter methylation status was available for 20 out of the 22 samples in GSE232173.